文献速递创伤骨科骨质疏松与代谢性骨病

急性老年病房治疗髋部骨折患者口服双膦酸盐处方及12个月不依从性

Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
PubMed 文献 · Osteoporos Int · 2018-08-03

前瞻性研究纳入368例因骨脆性髋部骨折在急性老年病房治疗的患者,出院时226例(61.42%)获口服双膦酸盐处方;12个月随访160例(70.7%),其中104例(65%)不依从。双变量分析显示年龄、Lawton和Brody指数、基线及入院和出院Barthel指数、基线功能性步行分类与不依从相关;多变量分析中基线Barthel指数为预测因素,OR 0.980(95%CI 0.965-0.995,p=.007),模型AUC 0.634(95%CI 0.545-0.722)。作者认为骨折时功能状态较差可预测不依从,并提示该高危人群二级骨折预防存在进一步优化空间。

要点

  • 12个月随访160例中104例(65%)对口服双膦酸盐不依从。
  • 多变量分析中基线Barthel指数OR 0.980(95%CI 0.965-0.995,p=.007)。
  • 模型判别能力AUC 0.634(95%CI 0.545-0.722)。

核心结论

  • 12个月时该模型中口服双膦酸盐治疗依从性低,治疗前较低的Barthel指数是不依从的预测因素。
  • 骨折时功能状态较差是不依从的预测因素,并提示该高危人群二级骨折预防存在进一步优化机会。

研究设计与样本

  • 前瞻性研究,分析骨脆性髋部骨折患者出院12个月时口服双膦酸盐不依从的相关因素与多变量预测因素,统计使用SPSS 19.0.0。
  • 共接诊368例骨脆性髋部骨折患者,出院时226例(61.42%)获口服双膦酸盐处方,12个月随访160例(70.7%)。

主要发现

  • 12个月随访的160例中104例(65%)不依从口服双膦酸盐。
  • 双变量分析(依从组 vs 不依从组):年龄83.79 ± 5.82 vs 85.78 ± 5.80(p=.029)。
  • 双变量分析(依从组 vs 不依从组):Lawton和Brody指数4.29 ± 3.40 vs 2.67 ± 3.31(p=.004)。
  • 双变量分析(依从组 vs 不依从组):基线Barthel指数85.89 ± 21.99 vs 74.18 ± 26.70(p=.004);入院Barthel指数18.84 ± 10.00 vs 14.47 ± 11.71(p=.004);出院Barthel指数34.20 ± 15.40 vs 27.45 ± 16.71(p=.011)。
  • 双变量分析(依从组 vs 不依从组):基线功能性步行分类5.66 ± 0.98 vs 5.43 ± 0.99(p=.025)。

关键数值与推荐

  • 多变量分析:Barthel指数OR 0.980(95%CI 0.965-0.995,p=.007)。
  • 模型判别能力AUC(±95%CI)0.634(0.545-0.722)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: A poorer functional status at the time of fracture is a predictor of non-adherence to oral bisphosphonates initiated after a hip fracture, and suggests further opportunities for optimization of secondary fracture prevention in this high-risk population. INTRODUCTION: Low adherence to treatment is a problem in post-fracture secondary prevention. We aimed to analyze the prognostic factors (related and predictive) associated with non-adherence to oral bisphosphonate prescription for hip fracture due to bone fragility (HFBF) 12 months after discharge from an acute geriatric unit. METHODS: Prospective study of bivariate data analyzing related and multivariate factors predicting non-adherence of oral bisphosphonates at 12 months after treatment for HFBF. The statistical study was performed with SPSS 19.0.0. RESULTS: We attended 368 patients with HFBF. At discharge, oral bisphosphonates were prescribed to 226 (61.42%) patients. At 12 months, we followed up 160 (70.7%) patients, 104 (65%) of whom had non-adherence to oral bisphosphonates. Bivariate analysis (adherent vs. non-adherent): age (83.79 ± 5.82 vs. 85.78 ± 5.80, p = .029); Lawton and Brody Index (4.29 ± 3.40 vs. 2.67 ± 3.31, p = .004); baseline Barthel Index (BI) (85.89 ± 21.99 vs. 74.18 ± 26.70) (p = .004); BI at admission (18.84 ± 10.00 vs. 14.47 ± 11.71, p = .004); BI at discharge (34.20 ± 15.40 vs. 27.45 ± 16.71, p = .011); baseline Functional Ambulation Classification (5.66 ± 0.98 vs. 5.43 ± 0.99, p = .025). Multivariate analysis: BI 0.980 (0.965-0.995, p = .007). Discriminatory capacity of the AUC model (± 95% CI): 0.634 (0.545-0.722). CONCLUSIONS: At 12 months, there was low adherence to treatment with oral bisphosphonates in our model. A lower BI prior to treatment is a predictive factor for non-adherence treatment with oral bisphosphonate.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Gamboa A, Duaso E, Marimón P, et al. Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit. Osteoporos Int. 2018. PMID: 30076454. doi:10.1007/s00198-018-4622-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。